- Report
- October 2024
- 196 Pages
Global
From €3382EUR$3,545USD£2,833GBP
€3758EUR$3,939USD£3,148GBP
- Report
- August 2024
- 381 Pages
Global
From €4579EUR$4,799USD£3,836GBP
- Report
- January 2024
- 213 Pages
Global
From €5248EUR$5,500USD£4,396GBP
- Report
- February 2024
- 202 Pages
Global
From €4771EUR$5,000USD£3,996GBP
- Report
- October 2024
- 185 Pages
Global
From €3382EUR$3,545USD£2,833GBP
€3758EUR$3,939USD£3,148GBP
- Report
- October 2024
- 180 Pages
Global
From €3382EUR$3,545USD£2,833GBP
€3758EUR$3,939USD£3,148GBP
- Report
- October 2024
- 182 Pages
Global
From €3382EUR$3,545USD£2,833GBP
€3758EUR$3,939USD£3,148GBP
- Report
- October 2024
- 195 Pages
Global
From €3382EUR$3,545USD£2,833GBP
€3758EUR$3,939USD£3,148GBP
- Report
- October 2024
- 199 Pages
Global
From €3382EUR$3,545USD£2,833GBP
€3758EUR$3,939USD£3,148GBP
- Report
- August 2024
- 100 Pages
Global
From €5677EUR$5,950USD£4,755GBP
- Report
- March 2024
- 133 Pages
Global
From €5677EUR$5,950USD£4,755GBP
- Report
- October 2024
- 190 Pages
Global
From €3382EUR$3,545USD£2,833GBP
€3758EUR$3,939USD£3,148GBP
- Report
- February 2024
- 175 Pages
Global
From €4771EUR$5,000USD£3,996GBP
- Report
- February 2024
- 200 Pages
Global
From €4771EUR$5,000USD£3,996GBP
- Report
- November 2023
- 110 Pages
Global
From €5677EUR$5,950USD£4,755GBP
- Report
- October 2024
- 376 Pages
Global
From €5200EUR$5,450USD£4,356GBP
- Report
- July 2024
- 334 Pages
Global
From €5343EUR$5,600USD£4,476GBP
- Report
- September 2024
- 150 Pages
Global
From €4627EUR$4,850USD£3,876GBP
- Report
- July 2024
- 175 Pages
Global
From €4771EUR$5,000USD£3,996GBP
- Report
- February 2024
- 250 Pages
Global
From €4771EUR$5,000USD£3,996GBP
DNA vaccines are a type of genomics-based vaccine that uses genetic material from a virus or bacteria to stimulate an immune response. They are created by introducing a gene that codes for a specific antigen into a plasmid, which is then inserted into a host cell. The host cell then produces the antigen, which is then used to stimulate an immune response. DNA vaccines are considered to be safer than traditional vaccines, as they do not contain any live virus or bacteria. Additionally, they can be produced more quickly and cheaply than traditional vaccines.
DNA vaccines have been used to treat a variety of diseases, including influenza, malaria, and HIV. They have also been used to develop vaccines for cancer and other diseases. Recently, DNA vaccines have been used to develop vaccines for the prevention of infectious diseases, such as Zika virus and Ebola.
Companies in the DNA Vaccines market include Moderna, Inovio Pharmaceuticals, Novavax, and Transgene. Show Less Read more